This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 June 2024 and includes updates on cholera, chikungunya and dengue, influenza,

This After-Action Review (AAR) investigates the use of evidence in Norway’s advice-making process about school continuity in secondary (13–15 years old) and upper secondary schools

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season

Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels.

This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection

This downloadable data file contains information on COVID-19 vaccination in the EU/EEA since September 2023.

Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur

Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 April 2024 and includes updates on respiratory virus epidemiology in the

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 April – 4 May 2024 and includes updates on cholera, MERS-CoV,

Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur

This report presents an interim description of COVID-19 vaccine coverage in the EU/EEA between 1 September 2023 and 15 April 2024.